BioMarker Strategies
Business Services · Maryland, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
15601 Crabbs Branch Way, Rockville, Mary...Phone Number
(410) 522-1008Website
www.biomarkerstrategies.comRevenue
<$5 MillionIndustry
About BioMarker Strategies
BioMarker Strategies Org Chart
Is BioMarker Strategies your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if BioMarker Strategies is spiking on competitors!
Check if BioMarker Strategies has recently received funding, and reach out quickly before it becomes old news!
Click to see if BioMarker Strategies had a recent Job posting/layoffs
BioMarker Strategies, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on BioMarker Strategies recently announced quarterly report
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when BioMarker Strategies launches new products
Congratulate Masked Content for being promoted to Masked Content at BioMarker Strategies
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once BioMarker Strategies has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to BioMarker Strategies
Compare insights from companies similar to BioMarker Strategies, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
BioMarker Strategies is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
BioMarker Strategies is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about BioMarker Strategies.
BioMarker Strategies financials insights
Gather financial insights about BioMarker Strategies, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Private Equity
$525K
Debt
$150K
BioMarker Strategies Tech Stack
A closer look at the technologies used by BioMarker Strategies
Most Recent Scoops
BioMarker Strategies News & Media
BioMarker Strategies to Present at BIO Digital Next Week
ROCKVILLE, Md.--(BUSINESS WIRE)--Jerry Parrott, President and CEO of BioMarker Strategies, will present at BIO Digital, which replaces BIO 2020, previously scheduled in San Diego.BioMarker Strategies Names Greg Bertenshaw Chief Operating and Science Officer
ROCKVILLE, Md.--(BUSINESS WIRE)--BioMarker Strategies, LLC today announced the promotion of Greg Bertenshaw, Ph.D., to Chief Operating and Science Officer, effective immediately.BioMarker Strategies Awarded Phase II National Cancer Institute Contract to Develop Novel Predictive Test for Response to Immunotherapies for Patients with Non-Small Cell Lung Cancer
ROCKVILLE, Md.--(BUSINESS WIRE)--NCI contract to BioMarker Strategies to develop PathMAP® Immunotherapy test to predict response to immunotherapies for Non-Small Cell Lung Cancer.BioMarker Strategies to Present at Biotech Showcase 2020 in San Francisco During J.P. Morgan Healthcare Conference Week
ROCKVILLE, Md.--(BUSINESS WIRE)--BioMarker Strategies presents to Biotech Showcase next week, and participates in RESI San Francisco and BIO One on One Partnering at JPM.
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding BioMarker Strategies
BioMarker Strategies is a privately-held molecular diagnostics company founded in 2006 at The Johns Hopkins Science & Technology Park in Baltimore, and now based in Rockville, Maryland. The Company's mission is to help make precision medicine more of a reality for patients with solid tumor cancers, by providing powerful new molecular tools and rese... Read More